Kite Pharma Inc. (KITE) stock starts with “Buy” rating in note to investors by HC Wainwright

Kite Pharma Inc. (NASDAQ: KITE) shares rose on Monday Nov 21 with lower trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile, stocks were set to open higher this morning. The Dow Jones Industrial Average futures YMZ6, +0.20% was 10 points, or less than 0.1%, higher at 18,863, while S&P 500 index futures ESZ6, +0.44% rose 3.95 points, or 0.2%, at 2,184.75. Nasdaq-100 NQZ6, +0.74% added 12.25 points, or 0.2%, to 4,820.75.

Analysts at HC Wainwright initiated coverage on Kite Pharma Inc. (NASDAQ: KITE) stock, starting the company at Buy. HC Wainwright currently has a rating of Buy on the stock. The one-year price target of $74.73 is above the opening price of $52.63, resulting a number of other analysts to report on the stock in recent days. Looking back over the last 52 weeks, Kite Pharma Inc. stock has a high of $87.50. After beginning or initiating coverage, analysts and brokerage firms will subsequently re periodic updates. Price changes targets are not uncommon.

Shares of Kite Pharma Inc. (NASDAQ: KITE) opened at $52.63 on Monday trading between $52.60 and $54.40, and last traded at $52.96, which represents an increase of $1.16 or 2.24% over the previous closing price.

Kite Pharma Inc. (NASDAQ: KITE) currently has a market cap of 2.64B.

Kite Pharma Inc. (NASDAQ: KITE) Average Daily Trading Volume

424,959 shares crossed the trading desk yesterday, lower than the average, out of a total float 40,471,000. Swing traders often use swings in trading volume to determine substantial volume accumulation or distribution by institutional investors, so trading volume is likely to increase in the next few days.

However, a single day of high volume buy side trading is not enough to determine a trend. So market traders will continue to look for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts researching thousands of stocks, so it is good confirmation to see them taking a postion in a stock you’re considering.

Kite Pharma Inc. (NASDAQ: KITE) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By marking the activity of these professional investors—and the moving averages they influence— traders are able to make make the best trades.

Trades for Kite Pharma Inc. (NASDAQ: KITE) have ranged from $38.41 – 87.50, and the stock now has a 50-day MA of $49.31 and 200-day MA of $52.10. Today’s last price is 39.47%% below the 52 week high of $87.50.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors seek companies that have increased their earnings by at least 25% for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.